Matches in SemOpenAlex for { <https://semopenalex.org/work/W2397572398> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2397572398 endingPage "102S" @default.
- W2397572398 startingPage "96S" @default.
- W2397572398 abstract "Isradipine is a new dihydropyridine calcium antagonist with a high degree of selectivity for the coronary, cerebral, and skeletal muscle vasculature. The drug has minimal depressant activity on sinoatrial node automaticity and negligible negative chronotropic, dromotropic, and inotropic actions. Isradipine reduces blood pressure and systemic vascular resistance without changes in cardiac output and stroke volume. Renal blood flow is maintained while renal vascular resistance is reduced; this is accompanied by both short- and long-term diuretic and natriuretic effects. Doses of 1.25 to 5 mg twice daily lowers blood pressure effectively over 24 h. In open as well as placebo-controlled trials, 2.5 to 10 mg isradipine twice daily was safe and well tolerated, and reduced systolic and diastolic values in up to 85% of patients with mild-to-moderate hypertension. Efficacy is similar to those of nifedipine and nitrendipine, and potentially superior to those of propranolol, atenolol, prazosin, hydrochlorothiazide, and diltiazem. The drug can be safely combined with beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and diuretics. Adverse effects are dose-dependent and secondary to arterial vasodilatation, such as headache, flushing, ankle edema, dizziness, palpitations, and tachycardia. At the recommended dose of 2.5 mg twice daily, the total incidence of side effects does not differ from that with placebo. The antiatherosclerotic, antitrophic, and cerebroprotective effects seen in experimental animal models are promising for the drug in the treatment of human hypertension. Isradipine may not only reduce blood pressure, but may also reduce the risk for the consequences of this peril, namely, cerebral stroke and myocardial infarction." @default.
- W2397572398 created "2016-06-24" @default.
- W2397572398 creator A5067901119 @default.
- W2397572398 date "1991-02-01" @default.
- W2397572398 modified "2023-09-26" @default.
- W2397572398 title "The Place of Isradipine in the Treatment of Hypertension" @default.
- W2397572398 doi "https://doi.org/10.1093/ajh/4.2.96s" @default.
- W2397572398 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1827026" @default.
- W2397572398 hasPublicationYear "1991" @default.
- W2397572398 type Work @default.
- W2397572398 sameAs 2397572398 @default.
- W2397572398 citedByCount "9" @default.
- W2397572398 countsByYear W23975723982018 @default.
- W2397572398 countsByYear W23975723982021 @default.
- W2397572398 crossrefType "journal-article" @default.
- W2397572398 hasAuthorship W2397572398A5067901119 @default.
- W2397572398 hasConcept C126322002 @default.
- W2397572398 hasConcept C164705383 @default.
- W2397572398 hasConcept C2776066529 @default.
- W2397572398 hasConcept C2780361556 @default.
- W2397572398 hasConcept C2780548744 @default.
- W2397572398 hasConcept C2781212610 @default.
- W2397572398 hasConcept C42219234 @default.
- W2397572398 hasConcept C519063684 @default.
- W2397572398 hasConcept C58245268 @default.
- W2397572398 hasConcept C71924100 @default.
- W2397572398 hasConcept C84393581 @default.
- W2397572398 hasConcept C98274493 @default.
- W2397572398 hasConceptScore W2397572398C126322002 @default.
- W2397572398 hasConceptScore W2397572398C164705383 @default.
- W2397572398 hasConceptScore W2397572398C2776066529 @default.
- W2397572398 hasConceptScore W2397572398C2780361556 @default.
- W2397572398 hasConceptScore W2397572398C2780548744 @default.
- W2397572398 hasConceptScore W2397572398C2781212610 @default.
- W2397572398 hasConceptScore W2397572398C42219234 @default.
- W2397572398 hasConceptScore W2397572398C519063684 @default.
- W2397572398 hasConceptScore W2397572398C58245268 @default.
- W2397572398 hasConceptScore W2397572398C71924100 @default.
- W2397572398 hasConceptScore W2397572398C84393581 @default.
- W2397572398 hasConceptScore W2397572398C98274493 @default.
- W2397572398 hasIssue "2_Pt_2" @default.
- W2397572398 hasLocation W23975723981 @default.
- W2397572398 hasLocation W23975723982 @default.
- W2397572398 hasOpenAccess W2397572398 @default.
- W2397572398 hasPrimaryLocation W23975723981 @default.
- W2397572398 hasRelatedWork W1518262917 @default.
- W2397572398 hasRelatedWork W1976374605 @default.
- W2397572398 hasRelatedWork W2033603050 @default.
- W2397572398 hasRelatedWork W2063046144 @default.
- W2397572398 hasRelatedWork W2081752448 @default.
- W2397572398 hasRelatedWork W2116515367 @default.
- W2397572398 hasRelatedWork W2397572398 @default.
- W2397572398 hasRelatedWork W2407204482 @default.
- W2397572398 hasRelatedWork W2413737953 @default.
- W2397572398 hasRelatedWork W2940071317 @default.
- W2397572398 hasVolume "4" @default.
- W2397572398 isParatext "false" @default.
- W2397572398 isRetracted "false" @default.
- W2397572398 magId "2397572398" @default.
- W2397572398 workType "article" @default.